RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109 | -14.8% | 100,246 | +1.4% | 0.00% | – |
| Q2 2023 | $128 | -14.1% | 98,874 | -12.4% | 0.00% | – |
| Q1 2023 | $149 | -8.6% | 112,821 | +3.8% | 0.00% | – |
| Q4 2022 | $163 | -99.9% | 108,713 | 0.0% | 0.00% | – |
| Q3 2022 | $129,000 | -32.1% | 108,713 | -35.4% | 0.00% | – |
| Q2 2022 | $190,000 | -23.4% | 168,302 | +102.5% | 0.00% | – |
| Q1 2022 | $248,000 | +72.2% | 83,102 | +52.6% | 0.00% | – |
| Q4 2021 | $144,000 | -31.4% | 54,456 | -6.0% | 0.00% | – |
| Q3 2021 | $210,000 | -15.0% | 57,956 | +2.0% | 0.00% | – |
| Q2 2021 | $247,000 | +64.7% | 56,847 | +29.3% | 0.00% | – |
| Q1 2021 | $150,000 | +265.9% | 43,952 | +278.5% | 0.00% | – |
| Q4 2020 | $41,000 | +36.7% | 11,612 | -7.2% | 0.00% | – |
| Q3 2020 | $30,000 | +30.4% | 12,512 | 0.0% | 0.00% | – |
| Q2 2020 | $23,000 | -99.6% | 12,512 | -99.7% | 0.00% | -100.0% |
| Q1 2020 | $6,146,000 | -24.9% | 3,939,869 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $8,189,000 | +14.8% | 3,826,406 | +0.3% | 0.00% | 0.0% |
| Q3 2019 | $7,133,000 | -46.4% | 3,814,699 | -25.1% | 0.00% | -50.0% |
| Q2 2019 | $13,301,000 | +1.6% | 5,096,227 | +0.0% | 0.00% | 0.0% |
| Q1 2019 | $13,096,000 | +24.8% | 5,095,827 | +11.7% | 0.00% | 0.0% |
| Q4 2018 | $10,494,000 | -28.1% | 4,562,621 | +0.3% | 0.00% | 0.0% |
| Q3 2018 | $14,596,000 | +45.7% | 4,547,115 | +28.4% | 0.00% | 0.0% |
| Q2 2018 | $10,021,000 | +5.4% | 3,540,851 | +31.8% | 0.00% | 0.0% |
| Q1 2018 | $9,508,000 | -8.7% | 2,685,759 | +0.1% | 0.00% | 0.0% |
| Q4 2017 | $10,414,000 | +47.4% | 2,683,953 | -3.5% | 0.00% | +100.0% |
| Q3 2017 | $7,064,000 | +9.6% | 2,781,153 | +17.8% | 0.00% | 0.0% |
| Q2 2017 | $6,444,000 | -29.3% | 2,360,603 | -14.3% | 0.00% | -50.0% |
| Q1 2017 | $9,115,000 | +123.5% | 2,753,833 | +60.7% | 0.00% | +100.0% |
| Q4 2016 | $4,079,000 | +14.1% | 1,714,030 | +75.9% | 0.00% | 0.0% |
| Q3 2016 | $3,576,000 | +662.5% | 974,365 | +363.2% | 0.00% | – |
| Q2 2016 | $469,000 | +7.1% | 210,360 | 0.0% | 0.00% | – |
| Q1 2016 | $438,000 | -31.7% | 210,360 | -0.6% | 0.00% | – |
| Q4 2015 | $641,000 | +16.8% | 211,650 | -4.9% | 0.00% | – |
| Q3 2015 | $549,000 | -23.0% | 222,450 | +0.1% | 0.00% | – |
| Q2 2015 | $713,000 | -10.1% | 222,200 | 0.0% | 0.00% | – |
| Q1 2015 | $793,000 | +60.9% | 222,200 | +2.3% | 0.00% | – |
| Q4 2014 | $493,000 | +17.1% | 217,200 | 0.0% | 0.00% | – |
| Q3 2014 | $421,000 | -46.6% | 217,200 | 0.0% | 0.00% | – |
| Q2 2014 | $788,000 | +28.5% | 217,200 | +37.5% | 0.00% | – |
| Q1 2014 | $613,000 | -96.3% | 157,920 | -96.6% | 0.00% | -100.0% |
| Q3 2013 | $16,510,000 | -50.2% | 4,611,800 | -53.6% | 0.00% | 0.0% |
| Q2 2013 | $33,164,000 | – | 9,929,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |